Judge Tosses Hedge Fund’s Lawsuit Against Neiman Marcus (The Wall Street Journal) A Texas judge Tuesday dismissed a bondholder lawsuit against Neiman......
(read more)March 19 - Hedge Funds, Insider Trading - Comments
Warren Buffett Explains How He Used to Short Stocks (GuruFocus) Warren Buffett is possibly the financial world’s most vocal critic of hedge funds......
(read more)March 12 - Hedge Funds, Insider Trading - Comments
Ray Dalio, Manager of the World’s Biggest Hedge Fund, Lowers His Odds of a Recession (CNBC) After seeing a “significant risk” of a recession......
(read more)February 28 - Hedge Funds, Insider Trading - Comments
Steve Cohen’s Venture Firm Invests in U.S. Cybersecurity Company (Reuters) NEW YORK (Reuters) – Billionaire investor Steve Cohen’s Point72......
(read more)February 20 - Hedge Funds, Insider Trading - Comments
Healthcare sector has proven itself to be one of the most resilient sectors of the US economy. Since healthcare cannot be outsourced and represents an......
(read more)March 11 - Hedge Funds, News - Comments
Etsy Inc (NASDAQ:ETSY) (Fortune) Etsy’s stock price jumped as much as 24% in midday trading on Wednesday, and has now more than doubled from a year......
(read more)February 28 - Market Movers, News - Comments
The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy. They seem to prefer......
(read more)February 5 - Hedge Funds, News - Comments
Mott Capital Management is a thematic growth fund that was founded in 2014 by Michael J. Kramer. Mr. Kramer manages a long-only thematic growth portfolio......
(read more)January 17 - Hedge Fund Investor Letters, Hedge Funds, News - Comments
By Khojinur Usmonov From low costs to expedited drug approval, President Trump recently met with big pharma CEOs about overhauling the entire system.......
(read more)February 23 - News, Stock Analysis - Comments
Five months ago, Delinia was just a fledgling autoimmune startup with just four full-time staff. However, the story is now totally different because Celgene......
(read more)January 27 - News, Stock Analysis - Comments
Celgene Corporation (NASDAQ:CELG) announced today its 2017 GAAP earnings per share of $5.85–$6.21. The company has expressed its expectations of revenues......
(read more)January 25 - News, Stock Analysis - Comments
Earlier this year, we looked at a privately held biotech called Jounce Therapeutics. At the time (Mid July) the company had struck a deal with Celgene......
(read more)January 3 - News, Stock Analysis - Comments
Julian Robertson is one of the most scrutinized investors on Wall Street, even though he closed his Tiger Management fund back in 2000. Even though Tiger......
(read more)December 16 - Hedge Funds, News, Tech - Comments
Celgene Corporation (NASDAQ:CELG) has recently unveiled the results from the randomized, Phase 2 tnAcity clinical trial evaluating Abraxane for injectable......
(read more)December 8 - News, Stock Analysis - Comments
bluebird bio Inc (NASDAQ:BLUE) is up sharply pre market on Thursday, as the company put out fresh interim data from a phase I study of its multiple myeloma......
(read more)December 1 - News, Stock Analysis - Comments
GlobeImmune Inc (OTCMKTS:GBIM) shareholders did not have a good week last week. The company put out a press release outlining its latest developments,......
(read more)November 21 - News, Stock Analysis - Comments
Introduction Financial metrics such as P/E ratios, price to cash flow ratios, PEG ratios, price to sales ratios, price to book value, and many others,......
(read more)November 4 - News, Stock Analysis - Comments
Markets are bearish on Wednesday as investors await minutes from the Federal Open Market Committee’s September meeting, which would likely give an idea......
(read more)October 12 - Market Movers, News - Comments
It was back in April when the Chief Medical Officer of pharma giant Celgene Corporation (NASDAQ:CELG), Dr. Jerome B. Zeldis joined the board of MetaStat......
(read more)October 10 - News, Stock Analysis - Comments
Extensive research shows that corporate insiders tend to make more profit-generating trades than the average non-insider, which serves as the primary......
(read more)September 27 - Insider Trading, News - Comments
U.S. stocks are trading down on Tuesday, driven by a series of weak earnings reports and anticipation (or is it dread?) surrounding both the results of......
(read more)July 26 - Market Movers, News - Comments
Markets inched up before the bell on Monday amid news that recent polls indicated that the British voters are now more inclined towards staying in the......
(read more)June 20 - Market Movers, News - Comments
All three index futures are in the green as traders await the Fed’s upcoming interest rate decision later today. If rates remain low, the U.S. and......
(read more)June 15 - Market Movers, News - Comments
Among some 800 hedge funds we track at Insider Monkey, we seldom come across funds that specialize in investing in a particular sector or have a penchant......
(read more)May 16 - Hedge Funds, News - Comments
Birchview Capital is a Vermont-based biosciences-focused long/short equity hedge fund founded by Dr. Matthew Strobeck in 2014. Dr. Strobeck holds a Ph......
(read more)May 15 - Hedge Funds, News - Comments
It’s the middle of earnings season and many investors are hungrily dissecting earnings reports and management commentary to get a better view on......
(read more)April 28 - Market Movers, News - Comments
Markets were tumbling on Monday, with all major U.S. stock indexes down substantially, driven by a selloff in tech stocks and a decline in oil prices.......
(read more)February 8 - Market Movers, News - Comments
The insider trading activity was very torpid in the past two holiday-shortened trading weeks, but several companies still witnessed heavy insider selling......
(read more)January 4 - Insider Trading, News - Comments
Wall Street is rising on Wednesday with all three major indexes trading in the green and shares of Freeport-McMoRan Inc (NYSE:FCX), ArcelorMittal SA (......
(read more)December 23 - Market Movers, News - Comments
Financial advisors employ considerable resources to identify the best stocks that they could provide advice on to their customers. Therefore, imitating......
(read more)December 10 - News - Comments
Mariner Investment Group is a New York-based investment advisory firm founded by William Michaelcheck in 1992. Apart from its headquarters in New York......
(read more)November 13 - Hedge Fund Analysis, Hedge Funds, News - Comments
Massachusetts-based Arrowstreet Capital recently has issued its latest 13F filing with the Securities and Exchange Commission for the reporting quarter......
(read more)November 12 - Hedge Funds, News - Comments
Sivik Global Healthcare is a Greenwich, Connecticut-based healthcare-focused hedge fund founded by Krishen Sud in 2006. In 2011, the fund merged with......
(read more)November 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
Beech Hill Advisors is a New York-based registered investment advisor founded by Paul Cantor and Joseph Weiss in 1987. Mr. Cantor has been an investment......
(read more)November 6 - Hedge Funds, News - Comments
Three notable companies were given upgrades by analysts this morning, mostly due to recent weakness in the price of their shares (but then, few stocks......
(read more)October 1 - Hedge Funds, News - Comments
Silver Arrow Partners, L.P, a New York-based fund, reported returns of 1.04% for the second quarter of 2015 along with year-to-date returns of 0.75%......
(read more)July 23 - Hedge Funds, News - Comments
The shares of both Receptos Inc (NASDAQ:RCPT) and Celgene Corporation (NASDAQ:CELG) are trading 10% higher after the two pharmaceutical companies entered......
(read more)July 15 - Hedge Funds, News - Comments
Juno Therapeutics Inc (NASDAQ:JUNO) jumped to a $67.22 per share pre-market high today, or 45.18% from the stock’s closing price yesterday, as the company......
(read more)June 30 - Hedge Funds, News - Comments
Matthew Hulsizer‘s Peak6 Investments, L.P. has filed its 13F with the SEC for the reporting period of March 31. Hulsizer, the co-founder and chief......
(read more)May 15 - Hedge Funds, News - Comments
Matthew Tewksbury‘s Stevens Capital Management has disclosed its equity holdings in a 13F filing with the SEC for the reporting period of March......
(read more)May 11 - Hedge Funds, News - Comments
Dr. Matthew Strobeck‘s Birchview Capital has recently disclosed its equity holdings in a 13F filing with the SEC. The market value of the fund&#......
(read more)April 29 - Hedge Funds, News - Comments
Celgene, Shire Make Five as Kyle Bass Expands Drug Patent Fight (Bloomberg) Hedge fund manager Kyle Bass has expanded the number of drug companies whose......
(read more)April 23 - Hedge Funds - Comments
In the last couple of years, biotechnology industry has been a hot topic and investors have been watching closely as the industry gained on average 40......
(read more)March 23 - Hedge Funds, News - Comments
With the high volatility prevalent in the biotechnology sector, investors have a hard time picking the right stocks to invest in. Moreover, due to the......
(read more)February 23 - Hedge Funds, News - Comments
The stage is set for the 56th American Society of Hematology (ASH) conference from Dec 6-9 at San Francisco. Plenty of pharmaceutical and biotech companies......
(read more)December 7 - News - Comments
Biogen Idec Inc (NASDAQ:BIIB) and Gilead Sciences, Inc. (NASDAQ:GILD) are two of the hottest stocks in biotech today, and should be jumped on now according......
(read more)September 6 - News, Stock Analysis - Comments
Who’s buying Amgen, Inc. (NASDAQ:AMGN)? To the average investor, there are tons of metrics shareholders can use to analyze stocks. Some of the......
(read more)August 25 - News - Comments
Biogen Idec Inc. (NASDAQ:BIIB) investors: listen up. To many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten......
(read more)August 23 - News - Comments
Will Celgene Corporation (NASDAQ:CELG) burn you? Here’s some data to help answer that question. To many traders, hedge funds are perceived as overrated......
(read more)August 22 - News - Comments
Editor’s Note: Related tickers: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amgen, Inc. (NASDAQ:AMGN), Celgene Corporation......
(read more)August 5 - News - Comments
